Alzheimer's Blood Test: Medicare Coverage Urged

An Alzheimer's advocate from North Central Florida is championing federal legislation to enable Medicare coverage for Alzheimer's blood tests. Christina M. Ramos, executive director of Touching Hearts at Home, recently joined national advocates in Washington D.C. to support the Alzheimer's Screening and Prevention Act (ASAP Act).

This bipartisan proposal would permit Medicare to fund blood-based screening for Alzheimer's and related dementias, provided they receive FDA clearance. Proponents argue that such testing can lead to earlier and more precise identification of the disease. Ramos shared a personal connection, recounting her family's experience caring for her grandmother, whose Alzheimer's diagnosis took three years, highlighting the uncertainty and missed opportunities during that period.

According to the Alzheimer's Impact Movement, brain changes associated with Alzheimer's can begin two decades before symptoms manifest. Fewer than 10% of individuals with mild cognitive impairment receive a diagnosis, despite it being the stage where symptoms first emerge and treatments might be eligible. The ASAP Act requires congressional approval for Medicare to cover these routine screening tests. Ramos emphasized that over 580,000 Floridians live with Alzheimer's, a number projected to grow, urging a unified approach to this healthcare challenge.

Ramos commended Senators Rick Scott and Congressman Vern Buchanan for their co-sponsorship and support. She is encouraging Floridians, caregivers, and healthcare professionals to contact their federal representatives and advocate for the ASAP Act, stating that Florida families are awaiting congressional action.